Es gab 50 kürzliche Insider-Transaktionen für Biomea Fusion, Inc. (BMEA), darunter 37 Käufe und 6 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $33.01M und die gesamten Insider-Verkäufe auf $19.51M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Erdtmann Rainer M, Hitchcock Michael J.m., Chen Bihua. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — BMEA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-04-01 |
Erdtmann Rainer M |
See Remarks |
RSU-Zuteilung |
452,512 |
$1.49 |
$674.24K |
452,512 |
| 2026-04-01 |
Hitchcock Michael J.m. |
Interim CEO |
RSU-Zuteilung |
667,477 |
$1.49 |
$994.54K |
667,477 |
| 2025-12-31 |
Erdtmann Rainer M |
See Remarks |
Unbekannt |
- |
- |
- |
174,614 |
| 2025-12-11 |
Erdtmann Rainer M |
See Remarks |
Informierter Kauf |
30,000 |
$1.43 |
$43K |
723,027 |
| 2025-12-02 |
Hitchcock Michael J.m. |
Interim CEO |
Informierter Kauf |
100,000 |
$0.99 |
$99.18K |
115,000 |
| 2025-12-01 |
Erdtmann Rainer M |
See Remarks |
Informierter Kauf |
10,000 |
$1.05 |
$10.5K |
693,027 |
| 2025-11-28 |
Erdtmann Rainer M |
See Remarks |
Informierter Kauf |
40,000 |
$1.10 |
$44.05K |
683,027 |
| 2025-08-11 |
Erdtmann Rainer M |
See Remarks |
RSU-Zuteilung |
1,246,989 |
$1.53 |
$1.91M |
1,246,989 |
| 2025-08-11 |
Hitchcock Michael J.m. |
Interim CEO |
RSU-Zuteilung |
916,434 |
$1.53 |
$1.4M |
916,434 |
| 2025-08-01 |
Chen Bihua |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-07-22 |
Averill Julianne |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-07-22 |
Averill Julianne |
Director |
RSU-Zuteilung |
241,177 |
$1.82 |
$438.94K |
241,177 |
| 2025-06-11 |
Aguiar Eric |
Director |
RSU-Zuteilung |
91,970 |
$2.50 |
$229.93K |
91,970 |
| 2025-06-11 |
Faust Elizabeth |
Director |
RSU-Zuteilung |
91,970 |
$2.50 |
$229.93K |
91,970 |
| 2025-06-11 |
Ray Sumita |
Director |
RSU-Zuteilung |
91,970 |
$2.50 |
$229.93K |
91,970 |
| 2025-06-11 |
Chen Bihua |
10 Percent Owner |
RSU-Zuteilung |
91,970 |
$2.50 |
$229.93K |
91,970 |
| 2025-03-26 |
Hitchcock Michael J.m. |
Interim CEO |
RSU-Zuteilung |
350,000 |
$2.52 |
$882K |
350,000 |
| 2025-01-31 |
Erdtmann Rainer M |
See Remarks |
Schenkung (erhalten) |
10,000 |
- |
- |
19,400 |
| 2025-01-28 |
Erdtmann Rainer M |
See Remarks |
Schenkung (gegeben) |
40,000 |
- |
- |
673,027 |
| 2024-11-30 |
Valle Franco |
Chief Financial Officer |
RSU-Zuteilung |
495 |
$6.15 |
$3.05K |
42,995 |
| 2024-09-30 |
Hitchcock Michael J.m. |
Director |
Informierter Kauf |
10,000 |
$10.06 |
$100.6K |
15,000 |
| 2024-06-12 |
Aguiar Eric |
Director |
RSU-Zuteilung |
51,025 |
$4.63 |
$236.25K |
51,025 |
| 2024-06-12 |
Faust Elizabeth |
Director |
RSU-Zuteilung |
51,025 |
$4.63 |
$236.25K |
51,025 |
| 2024-06-12 |
Ray Sumita |
Director |
RSU-Zuteilung |
51,025 |
$4.63 |
$236.25K |
51,025 |
| 2024-06-12 |
Chen Bihua |
10 Percent Owner |
RSU-Zuteilung |
51,025 |
$4.63 |
$236.25K |
51 |
| 2024-06-12 |
Hitchcock Michael J.m. |
Director |
RSU-Zuteilung |
51,025 |
$4.63 |
$236.25K |
51,025 |
| 2024-06-11 |
Valle Franco |
Chief Financial Officer |
Informierter Kauf |
12,509 |
$4.43 |
$55.36K |
42,500 |
| 2024-05-31 |
Valle Franco |
Chief Financial Officer |
RSU-Zuteilung |
4,448 |
$3.78 |
$16.82K |
29,991 |
| 2024-05-31 |
Frias Juan Pablo |
Chief Medical Officer |
RSU-Zuteilung |
349 |
$8.94 |
$3.12K |
349 |
| 2024-01-17 |
Erdtmann Rainer M |
President and COO |
RSU-Zuteilung |
135,700 |
$14.44 |
$1.96M |
135,700 |
| 2024-01-17 |
Valle Franco |
Chief Financial Officer |
RSU-Zuteilung |
145,245 |
$14.44 |
$2.1M |
145,245 |
| 2024-01-17 |
Butler Thomas Andrew |
10 Percent Owner, Officer: Chief Executive Officer |
RSU-Zuteilung |
407,502 |
$14.44 |
$5.88M |
407,502 |
| 2024-01-17 |
Frias Juan Pablo |
Chief Medical Officer |
RSU-Zuteilung |
111,090 |
$14.44 |
$1.6M |
111,090 |
| 2023-12-29 |
Erdtmann Rainer M |
President and COO |
Schenkung (erhalten) |
3,000 |
- |
- |
9,400 |
| 2023-11-30 |
Valle Franco |
Chief Financial Officer |
RSU-Zuteilung |
1,345 |
$3.78 |
$5.09K |
25,543 |
| 2023-08-31 |
Frias Juan Pablo |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-08-31 |
Frias Juan Pablo |
Chief Medical Officer |
RSU-Zuteilung |
300,000 |
$16.87 |
$5.06M |
300,000 |
| 2023-06-14 |
Aguiar Eric |
Director |
RSU-Zuteilung |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-14 |
Faust Elizabeth |
Director |
RSU-Zuteilung |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-14 |
Ray Sumita |
Director |
RSU-Zuteilung |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-14 |
Chen Bihua |
10 Percent Owner |
RSU-Zuteilung |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-14 |
Hitchcock Michael J.m. |
Director |
RSU-Zuteilung |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-01 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informierter Verkauf |
50,000 |
$34.56 |
$1.73M |
3,500,000 |
| 2023-05-31 |
Valle Franco |
Chief Financial Officer |
RSU-Zuteilung |
4,273 |
$3.78 |
$16.16K |
24,198 |
| 2023-05-31 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informierter Verkauf |
75,000 |
$33.81 |
$2.54M |
3,550,000 |
| 2023-05-12 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informierter Verkauf |
25,000 |
$33.84 |
$846K |
3,625,000 |
| 2023-05-09 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informierter Verkauf |
150,000 |
$34.50 |
$5.18M |
3,650,000 |
| 2023-05-08 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informierter Verkauf |
100,000 |
$33.99 |
$3.4M |
3,800,000 |
| 2023-04-20 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informierter Verkauf |
200,000 |
$29.12 |
$5.82M |
3,900,000 |
| 2023-03-31 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informierter Kauf |
200,000 |
$31.25 |
$6.25M |
4,100,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
